Bryony H. Lloyd - Concepedia

Author

Bryony H. Lloyd

University of Liverpool

Also Known As

B H Lloyd, B Lloyd, B. H. Lloyd, B. Lloyd, Bryony H Lloyd, Bryony H. Lloyd, Bryony Lloyd, Helen Kalirai

Publications

917

Citations

H-Index

Concepts

All Affiliations

University of Liverpool Royal Liverpool University Hospital Royal Liverpool and Broadgreen University Hospital NHS Trust Clatterbridge Cancer Centre NHS Foundation Trust

About

Bryony H. Lloyd is an author at University of Liverpool specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	255
2	Cell Biology	4	4	166
3	Engineering	2	2	38
4	Public Health	1	1	15
5	Endocrinology	1	1	15

Bryony H. Lloyd

Publications

883

Citations

H-Index

Page 1

	Year	Citations
Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy Adam Lister, Taoufik Nedjadi, Neil R. Kitteringham, Molecular Cancer	2011	238
Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells Bryony H. Lloyd, Angela Platt‐Higgins, Philip S. Rudland, Oncogene Malignant DiseaseMedicinePathologyHuman S100a4Cancer Biology	1998	109
Introduction of a porcine growth hormone fusion gene into transgenic pigs promotes growth Peter D. Vize, Anna Michalska, Rod Ashman, Journal of Cell Science	1988	93
Nutlin-3, the small-molecule inhibitor of MDM2, promotes senescence and radiosensitises laryngeal carcinoma cells harbouring wild-type p53 Aditya Arya, Asem Elfert, Timothy Devling, British Journal of Cancer	2010	72
SERPINE1 and SMA expression at the invasive front predict extracapsular spread and survival in oral squamous cell carcinoma Jagtar Dhanda, Asterios Triantafyllou, Triantafillos Liloglou, British Journal of Cancer	2014	64
Single Nucleotide Polymorphism Array Analysis of Uveal Melanomas Reveals That Amplification of CNKSR3 Is Correlated With Improved Patient Survival Sarah L. Lake, Bertil Damato, Helen Kalirai, American Journal Of Pathology Improved Patient SurvivalCnksr3 Is CorrelatedMedicineMelanomaPathology	2013	44
CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia Gillian G. Johnson, Ke Lin, Trevor F. Cox, Blood	2013	41
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy Aidan P. Noon, Radosław Polański, Ashraf Y. El‐Fert, British Journal of Urology	2011	35
Localisation byin situ hybridisation of S100A4 (p9Ka) mrna in primary human breast tumour specimens Leonid L. Nikitenko, Bryony H. Lloyd, Philip S. Rudland, International Journal of Cancer	2000	34
Characterisation of molecular alterations in microdissected archival gliomas Carol Walker, Kathryn A. Joyce, Joanne Thompson-Hehir, Acta Neuropathologica Neuro-oncologyTumoral PathologyPathologyMolecular AlterationsHigh-grade Gliomas	2001	30

Page 1